Inverse relationship between patient peripheral blood CD34+ cell counts and collection efficiency for CD34+ cells in two automated leukapheresis systems

Transfusion

Volumn 41, Issue 8, 2001, Pages 1008-1013

  Heuft, Hans Gert ^a,b   Dubiel, Mark ^a   Rick, Oliver ^a   Kingreen, Dorothea ^a   Serke, Stefan ^a   Schwella, Nimrod ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD CELL COUNT; BLOOD SAMPLING; COMPARATIVE STUDY; FEMALE; HUMAN; INSTRUMENTATION; LEUKAPHERESIS; MALE; MIDDLE AGED; NONPARAMETRIC TEST; STANDARD;

ADOLESCENT; ADULT; ANTIGENS, CD34; BLOOD CELL COUNT; BLOOD SPECIMEN COLLECTION; FEMALE; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 0035434798     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41081008.x     Document Type: Article

References (30)

1. Williams SF, Bitran JD, Richards JM, et al. Peripheral blood-derived stem cell collections for use in autologous transplantation after high-dose chemotherapy: an alternative approach. Bone Marrow Transplant 1990;5:129-33.
2. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991;77:211-3.
3. Beyer J, Schwella N, Zingsem J, et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995;13:1328-35.
4. Ayash LJ, Elias A, Wheeler C, et al. Double dose-intensive chemotherapy with autologous marrow and peripheral blood progenitor cell support for metastatic breast cancer: a feasibility study. J Clin Oncol 1994;12:37-44.
5. Shea TC, Mason JR, Breslin M, et al. Reinfusion and serial measurements of carboplatin mobilized peripheral blood progenitor cells in patients receiving multiple cycles of high dose chemotherapy. J Clin Oncol 1994;2:1012-20.
6. Weinthal JA, Nemunaitis JJ, Aston S, et al. Analysis of apheresis content of progenitor cell collections from normal donors to whom granulocyte colony-stimulating factor is administered. Transfusion 1996;36:943-7.
7. Stroncek DF, Clay ME, Smith J, et al. Comparison of two blood cell separators in collecting peripheral blood stem cell components. Transfus Med 1997;7:95-9.
8. Hillyer CD, Tiegerman KO, Berkman EM. Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separator. Transfusion 1991;31:327-32.
9. Padley D, Strauss RG, Wieland M, et al. Concurrent comparison of the COBE Spectra and Fenwal CS3000 for the collection of peripheral blood mononuclear cells for autologous peripheral stem cell transplantation. J Clin Apheresis 1991;6:77-80.
10. Snyder EL, Baril L, Cooper DL, et al. In vitro collection and posttransfusion engraftment characteristics of MNCs obtained by using a new separator for autologous PBPC transplantation. Transfusion 2000;40:961-7.
11. Leibundgut K, Muff J, Hirt A, et al. Evaluation of the Fresenius cell separator AS104 for harvesting peripheral blood stem cells in pediatric patients. Transfus Sci 1994;15:93-9.
12. Menichella G, Lai M, Pierelli L, et al. Evaluation of two different protocols for peripheral blood stem cell collection with the Fresenius AS 104 blood cell separator. Vox Sang 1997;73:230-6.
13. Morton JA, Baker DP, Hutchins CJ, et al. The Cobe Spectra cell separator is more effective than the Haemonetics MCS-3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophosphamide and filgrastim. Transfusion 1997;37:631-3.
14. Bambi F, Faulkner LB, Azzari C, et al. Pediatric peripheral blood progenitor cell collection: Haemonetics MCS 3P versus COBE Spectra versus Fresenius AS 104. Transfusion 1998;38:70-4.
15. Dzieczkowski JS, McGonigal M, Cook J, et al. A comparison of peripheral blood stem cell apheresis using the Fenwal CS3000 Plus and COBE Spectra. Transfus Sci 1995;16:71-7.
16. Schreiner T, Wiesneth M, Krug E, et al. Collection of allogeneic peripheral blood progenitor cells by two protocols on an apheresis system. Transfusion 1998;38:1051-5.
17. Silvestri F, Fritsch G, Serke S, et al. Comparison of two monoclonal antibodies - 8G12 and QBEND10 - in detecting CD34+ circulating cells in the peripheral blood. Eur J Lab Med 1993;1:125-8.
18. Fauser AA, Messner HA. Granuloerythropoietic colonies in human bone marrow, peripheral blood and cord blood. Blood 1978;52:1243-8.
19. Ravagnani F, Siena S, De Keys S, et al. Improved collection of mobilized CD34+ hematopoietic progenitor cells by a novel automated leukapheresis system. Transfusion 1999;39:48-55.
20. Rowley SD, Prather K, Bui KT, et al. Collection of peripheral blood progenitor cells with an automated leukapheresis system. Transfusion 1999;39:1200-6.
21. Benjamin RL, Linsley L, Fountain D, et al. Preapheresis peripheral blood CD34+ mononuclear cells as predictors of progenitor cell yield. Transfusion 1997;37:79-85.
22. Murea S, Goldschmidt H, Hahn U, et al. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large volume leukapheresis. J Clin Apheresis 1996;11:185-94.
23. Elliott C, Samson DM, Armitage S, et al. When to harvest peripheral blood stem cells after mobilization chemotherapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996;14:970-3.
24. Schwella N, Beyer J, Schwaner I, et al. Impact of preleukapheresis cell counts on collection results and correlation of progenitor cell dose with engraftment after high dose chemotherapy in patients with germ cell cancer. J Clin Oncol 1996;14:1114-21.
25. Schots R, Van Riet I, Damiaens S, et al. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509-15.
26. Yu J, Leisenring W, Bensinger W, et al. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing and maximizing yields. Transfusion 1999;39:442-50.
27. Möhle R, Murea S, Pförsich M, et al. Estimation of the progenitor cell yield in a leukapheresis product by previous measurement of CD34+ cells in the peripheral blood. Vox Sang 1996;71:90-6.
28. Schwella N, Siegert W, Beyer J, et al. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution. Ann Hematol 1995;71:227-34.
29. Haas R, Möhle R, Frühauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-94.
30. Auer RL, Holtom P, Smith H, et al. Circulating CD34+ counts and apheresis planning. Hematol Oncol 1998;16:69-75.